Summarized by Daily Strand AI from peer-reviewed source
The human brain relies on a highly specialized workforce to stay healthy. For a long time, scientists neatly categorized these cellular workers. Microglia act as the immune and cleanup crew, while oligodendrocytes manufacture myelin, the protective insulation that coats nerve fibers. Now, researchers have discovered a fascinating hybrid. By looking at the genetic instructions of individual cells, they identified dual-phenotype microglia, or DPM. These unique cells simultaneously show the traits of both the immune cleanup crew and the insulation manufacturers.
The research team found that these hybrid cells come in two distinct varieties, each with its own job and location. The first type, called myelin-associated DPM, is scattered throughout the entire brain. Controlled by a genetic switch known as Sox10, these highly branched cells help maintain nerve insulation. The second type, neuron-associated DPM, operates quite differently. Governed by a different genetic controller called Glis2, these cells cluster tightly in the hippocampus, a brain region crucial for memory. There, they help regulate the delicate communication networks between neurons.
To make this discovery, scientists used a technique called single-cell transcriptomics, which allows them to read the exact genetic activity of individual cells alongside advanced physical mapping tools. While the findings are exciting, the researchers note that this is still early-stage preclinical work. The current study clearly maps out the genetics and physical locations of these hybrid cells, but further research in living models is required to fully confirm how they operate in a functioning brain.
This discovery could fundamentally shift how we understand and treat major neurodegenerative diseases. The researchers observed that these hybrid cells are deeply intertwined with brain pathology, particularly in multiple sclerosis and Alzheimer's disease. Most notably, they found that the myelin-associated hybrid cells cluster specifically in active multiple sclerosis lesions. Multiple sclerosis is a disease defined by the immune system destroying nerve insulation, so finding a cell that naturally possesses both immune and insulation-related qualities right at the site of damage is a major clue for scientists trying to understand brain repair.
Globally, millions of people live with multiple sclerosis and Alzheimer's disease, and current treatments often struggle to halt disease progression or restore lost function. By identifying a previously unknown cellular player, this research provides the medical field with a brand-new target for drug development. If future studies can figure out how to safely activate or support these hybrid cells, it could eventually lead to next-generation therapies that harness the brain's own built-in maintenance crew to repair nerve damage and protect cognitive function.
Interested in Genomics?
Newsletter
Never miss a breakthrough.
Join 10,000+ curious minds getting biotech stories distilled into plain language. Free, three times a week.